Skip to content

Biomarkers of salt-sensitive hypertension and associated target organ damage

Biomarkers of salt-sensitive hypertension and associated target organ damage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082493
Enrollment
Unknown
Registered
2024-03-29
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Salt-sensitive hypertension

Interventions

Trail group:None

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) 18 to 65 years old, gender is not limited; (2) Patients who were clearly diagnosed with primary hypertension, with reference to the Chinese Guidelines for the Prevention and Treatment of Hypertension (2018 Revision) for the basis of diagnostic criteria; (3) Patients who met the diagnostic criteria for salt-sensitive hypertension, with reference to the Chinese Expert Consensus on the Management of Salt-Sensitive Hypertension (2023) for the basis of diagnostic criteria; (4) Voluntary participation; (5) Complete clinical data and laboratory tests; (6) Written informed consent approved by the ethics committee should be signed by the patients or their legal representatives before screening.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary hypertension; (2) Women who have been pregnant or breastfeeding; (3) Patients with severe organic diseases, especially hepatic and renal dysfunction; (4) Acute heart failure, cardiogenic shock, acute coronary syndrome and previous myocardial infarction; (5) Acute stage of stroke (<3 months); (6) Patients with other severe organic diseases with a life expectancy of <12 months; (7) Illiteracy, impaired basic reading and writing functions, or inability to care for oneself; (8) Left ventricular ejection fraction < 50%; (9) Patients who were unsuitable for the study for any reason according to the judgment of the investigator.

Design outcomes

Primary

MeasureTime frame
Carotid intima-media thickness;Left ventricular hypertrophy;Estimated glomerular filtration rate;Urine microalbumin;

Secondary

MeasureTime frame
Pulse wave velocity;Ankle brachial pressure index;Cranial imaging;

Countries

China

Contacts

Public ContactWang Peijian

The First Affiliated Hospital of Chengdu Medical College

wpjmed@aliyun.com+86 189 8071 8263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026